Young David bought PCSA
April 30, 2026 · Form 4 insider transaction
Young David bought 1,706 shares of Processa Pharmaceuticals, Inc. at $2.69 per share, a transaction worth $4.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,706
Price
$2.69
Total value
$4.6K
InsiderYoung David
RoleOfficer, Director
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateApril 30, 2026
Filing dateMay 1, 2026
Shares owned after13,813
OwnershipDirect
10b5-1 planNo
AmendedNo